DK1710236T3 - Derivater af pyridin og quinolin - Google Patents

Derivater af pyridin og quinolin

Info

Publication number
DK1710236T3
DK1710236T3 DK05708100.2T DK05708100T DK1710236T3 DK 1710236 T3 DK1710236 T3 DK 1710236T3 DK 05708100 T DK05708100 T DK 05708100T DK 1710236 T3 DK1710236 T3 DK 1710236T3
Authority
DK
Denmark
Prior art keywords
quinoline
pyridine
derivatives
blocking
diseases
Prior art date
Application number
DK05708100.2T
Other languages
English (en)
Inventor
Sanjuan Juan Carlos Lacal
Rosa Joaquin Campos
Meza Miguel Angel Gallo
Ubeda Antonio Espinosa
Original Assignee
Consejo Superior Investigacion
Univ Granada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior Investigacion, Univ Granada filed Critical Consejo Superior Investigacion
Application granted granted Critical
Publication of DK1710236T3 publication Critical patent/DK1710236T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • C07D215/44Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK05708100.2T 2004-01-14 2005-01-11 Derivater af pyridin og quinolin DK1710236T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200400072A ES2237332B1 (es) 2004-01-14 2004-01-14 Derivados de piridinio y quinolinio.
PCT/ES2005/070002 WO2005068429A1 (es) 2004-01-14 2005-01-11 Derivados de piridinio y quinolinio

Publications (1)

Publication Number Publication Date
DK1710236T3 true DK1710236T3 (da) 2010-07-12

Family

ID=34778265

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05708100.2T DK1710236T3 (da) 2004-01-14 2005-01-11 Derivater af pyridin og quinolin

Country Status (16)

Country Link
US (1) US7781458B2 (da)
EP (2) EP1710236B1 (da)
JP (2) JP5047627B2 (da)
KR (1) KR101157206B1 (da)
CN (1) CN1910153B (da)
AT (1) ATE461918T1 (da)
BR (1) BRPI0506486A (da)
CA (1) CA2553328C (da)
DE (1) DE602005020112D1 (da)
DK (1) DK1710236T3 (da)
ES (2) ES2237332B1 (da)
HK (1) HK1100441A1 (da)
MX (1) MXPA06007940A (da)
PL (1) PL1710236T3 (da)
PT (1) PT1710236E (da)
WO (1) WO2005068429A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8586613B2 (en) * 2004-01-14 2013-11-19 Universidad De Granada Pyridinium and quinolinium derivatives
MX2011000147A (es) 2008-07-04 2011-05-24 Traslational Cancer Drugs Pharma S L Metodos para el tratamiento y diagnostico del cancer.
US20100068302A1 (en) * 2008-09-17 2010-03-18 Traslational Cancer Drugs Pharma, S.L. Methods and compositions for the treatment of cancer
US20110212994A1 (en) * 2009-06-26 2011-09-01 Brian Clem Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Safe and Effective Treatment of Neoplastic Disorders
WO2012041493A1 (en) * 2010-09-28 2012-04-05 Julius-Maximilians-Universität Würzburg Aminoquinolinium salts, methods of their production and their use as active agents for biotechnological and medical applications against binary toxins
EP2468259A1 (en) * 2010-12-23 2012-06-27 Traslational Cancer Drugs Pharma, S.L. Pharmaceutical compositions of pyridinium and quinolinium derivatives
WO2012175537A1 (en) 2011-06-20 2012-12-27 Traslational Cancer Drugs Pharma, S.L. Method for predicting the clinical response to chemotherapy in a subject with cancer
RU2014115979A (ru) * 2011-09-22 2015-10-27 Вертекс Фармасьютикалз Инкорпорейтед Соединения, используемые как ингибиторы холинкиназы
ES2472367B1 (es) * 2012-12-28 2015-06-02 Universidad De Granada Inhibidores no simétricos de colina quinasa con actividad antitumoral y antimalárica
WO2015028662A1 (en) 2013-08-30 2015-03-05 Consejo Superior De Investigaciones Cientificas (Csic) Compositions and methods for characterization and amelioration of rheumatoid arthritis
ES2482290B1 (es) * 2014-06-05 2015-05-19 Universidad De Granada Inhibidores polares simétricos de colina cinasa con actividad antitumoral
EP3487857B1 (en) 2016-07-25 2021-09-01 Nerviano Medical Sciences S.r.l. Purine and 3-deazapurine analogues as choline kinase inhibitors
JP7178401B2 (ja) 2017-07-11 2022-11-25 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ コリンキナーゼ阻害剤としてのピラゾロキナゾリン誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206215A (en) * 1976-02-25 1980-06-03 Sterling Drug Inc. Antimicrobial bis-[4-(substituted-amino)-1-pyridinium]alkanes
GB1533952A (en) * 1976-02-25 1978-11-29 Sterling Drug Inc Anti-microbial bis-pyridinium compounds
FR2498187A1 (fr) * 1981-01-16 1982-07-23 Rhone Poulenc Sante Procede de preparation d'amino-4 chloro-7 quinoleines
IL89026A (en) * 1988-01-29 1993-02-21 Lilly Co Eli Substituted quinolines and cinnolines, process for their preparation and fungicidal, insecticidal and miticidal compositions containing them
ES2117950B1 (es) 1996-08-02 1999-09-16 Univ Granada Nuevos compuestos que bloquean la biosintesis de fosforilcolina y su uso como segundo mensajero en proliferacion celular.

Also Published As

Publication number Publication date
CA2553328A1 (en) 2005-07-28
EP1710236B1 (en) 2010-03-24
US7781458B2 (en) 2010-08-24
WO2005068429A1 (es) 2005-07-28
KR101157206B1 (ko) 2012-07-06
EP2085386A2 (en) 2009-08-05
CN1910153B (zh) 2010-05-26
MXPA06007940A (es) 2007-01-23
EP2085386A3 (en) 2009-10-28
ES2237332B1 (es) 2006-11-01
EP1710236A1 (en) 2006-10-11
HK1100441A1 (en) 2007-09-21
ATE461918T1 (de) 2010-04-15
CA2553328C (en) 2012-05-15
JP5619805B2 (ja) 2014-11-05
DE602005020112D1 (de) 2010-05-06
PT1710236E (pt) 2010-06-18
JP2007517837A (ja) 2007-07-05
JP5047627B2 (ja) 2012-10-10
JP2012149077A (ja) 2012-08-09
CN1910153A (zh) 2007-02-07
US20070185170A1 (en) 2007-08-09
ES2343418T3 (es) 2010-07-30
ES2237332A1 (es) 2005-07-16
KR20060110364A (ko) 2006-10-24
BRPI0506486A (pt) 2007-02-13
PL1710236T3 (pl) 2010-08-31

Similar Documents

Publication Publication Date Title
DK1710236T3 (da) Derivater af pyridin og quinolin
NO20071843L (no) Substituerte anilinderivater
BR112012016111A2 (pt) Composto hererocíclico contendo nitrogênio, fungicida agrícola, e, produto intermediário
ATE432260T1 (de) Pyridinderivate als pkc-theta-hemmer
EA200601364A1 (ru) Производные хинолина и их применение в качестве ингибиторов микобактерий
CY1112402T1 (el) Ενισχυτες υποδοχεων γλουταμικου
NO20060665L (no) N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer
NO20070453L (no) Kondenserte heterocykliske kinase inhibitorer
SE0301373D0 (sv) Novel compounds
ATE390925T1 (de) Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
ECSP088121A (es) Derivados de pirrolo [2,3-b] piridina comoinhibidores de proteina cinasa
EA200800396A1 (ru) Гидроксизамещенные 1н-имидазопиридины и способы
NO20060670L (no) N3-substituerte imidazopyridin C-kit inhibitorer
EA200700286A1 (ru) Применение замещённых производных 2-пирролидона в качестве фунгицидов и инсектицидов
DE602006010243D1 (de) 4-(Phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamid Derivate als MEK Inhibitoren zur Behandlung von hyperproliferativen Erkrankungen
BRPI0516904A (pt) processo para a preparação de um derivado de 2-etilaminopiridina e composto
ATE532789T1 (de) Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren
MX2013004407A (es) Derivado de piridina y agente medicinal.
DE602005017626D1 (de) Antivirale verwendung von borinsäurekomplexen
CY1115809T1 (el) Φουραζανοβενζιμιδαζολες ως προφαρμακα για τη θεραπεια νεοπλασματικων ή αυτοανοσων ασθενειων
ATE493418T1 (de) Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren
ATE373643T1 (de) Als fungizide geeignete 2- pyridinylcycloalkylcarbonsäureamidderivate
ATE522509T1 (de) Pyrimidylcyclopentane als inhibitoren der akt- proteinkinase
ATE543803T1 (de) 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren